Paraoxonase Arg 192 allele is an independent risk factor for three-vessel stenosis of coronary artery disease
- 201 Downloads
The role of the paraoxonase (PON1) codon 192 polymorphism [glutamine (Q)/arginine (R)] in coronary artery disease (CAD) is controversial. The aim of the present study was to evaluate whether the PON1 gene polymorphism is an independent risk factor for severity of coronary artery disease in patients from west of Iran. The PON1-Arg-192 genotypes were detected by PCR-RFLP in 414 individuals undergoing their first coronary angiography. Patients were placed into one of two groups: CAD and control without CAD or diabetes. The frequency of PON1-Arg-192 allele was significantly higher in the CAD (23.4 vs. 16%, P = 0.032) than in the control group and there was a higher risk of developing CAD (OR = 1.6, P = 0.02). In addition, this difference remained significant after adjustment for without history of diabetes (OR = 1.47, P = 0.048), presence of normolipidemia and absence of history of blood pressure (OR = 1.4, P = 0.05). This result indicated PON1-Arg-192 allele is a risk factor of CAD also when correcting for conventional risk factors. We found a significant association between the PON1-Arg-192 genotype (QR + RR) and the extent of CAD in CAD patients and CAD subjects without diabetes, represented by the increased frequency of three-vessel disease with OR = 1.49, P = 0.046; χ2 = 3.82, P = 0.048 and OR = 1.46, P = 0.05; χ2 = 3.48, P = 0.051, respectively. The CAD patients carrying PON1-Arg-192 genotype (QR + RR) had lower plasma HDL-C level (P = 0.019) and higher plasma LDL-C(P = 0.01) and TG(P = 0.05). Our results indicated that PON1-Arg-192 allele can be important independent risk factor of CAD in a west population of Iran, with carriers of PON1-Arg-192 having an increased frequency of three-vessel disease and also having a distinct plasma lipids profile. Larger collaborative studies are needed to confirm these results.
KeywordsParaoxonase Coronary artery disease Diabetes mellitus Genetic polymorphism Lipid profile Vessel stenosis
This work was supported by the Kermanshah University of Medical Sciences, Kermanshah, Iran (grant numbers 86049); All authors contributed equally to this study. This research did not receive any specific grant from any funding agency in the public, commercial or not-for-profit sector.
Conflict of interest
- 4.Vaisi Raygani A, Rahimi Z, Entezami H, Kharrazi H, Bahrhemand F, Tavilani H, Rezaei M, Kiani A, Nomanpour B, Tavilani H, Pourmotabbed T (2008) Butyrylcholinesterase K ariants increase the risk of coronary artery disease in the population of western Iran. Scand J Clin Lab Invest 68(2):123–129PubMedCrossRefGoogle Scholar
- 7.Hatmi ZN, Tahvildari S, Gafarzadeh Motlag A, Sabouri Kashani A (2007) Prevalence of coronary artery disease risk factors in Iran: a population based survey. BMC Cardiovasc Disord 7(32):1–5Google Scholar
- 8.Imazio M, Bobbio M, Bergerone S, Barlera S, Maggioni AP (1998) Clinical and epidemiological characteristics of juvenile myocardial infarction in Italy: the GISSI experience. J Ital Cardiol 28(5):505–512Google Scholar
- 20.Aydin M, Gokkusu C, Ozkok E, Tulubas F, Unlucerci Y, Pamukcu B, Ozbek Z, Umman B (2009) Association of genetic variants in methylenetetrahydrofolate reductase and paraoxonase-1 genes with homocysteine, folate and vitamin B12 in coronary artery disease. Mol Cell Biochem 325:199–208PubMedCrossRefGoogle Scholar
- 23.Taskıran P, Cam SF, Sekuri C, Tuzun N, Alioglu E, Altıntas N, Berdeli A (2009) The relationship between paraoxanase gene Leu-Met (55) and Gln-Arg (192) polymorphisms and coronary artery disease. Arch Turk Soc Cardiol 37(7):473–478Google Scholar
- 27.World Health Organization (1999) WHO Study Group Report of a WHO consultation: part 1. Diagnosis and classification of diabetes mellitus. World Health Organization, GenevaGoogle Scholar
- 32.Debbie T, Lawlor A, Day INM, Gaunt TR, Hinks LJ, Briggs PJ, Kiessling M, Timpson N, Smith GD, Ebrahim S (2004) The association of the PON1 Q192R polymorphism with coronary heart disease: findings from the British Women’s heart and health cohort study and a meta-analysis. BMC Genetics 5(17):1–13Google Scholar
- 39.Rahimi Z, Felehgari V, Rahimi M, Mozafari H, Yari K, Vaisi-Raygani A, Rezaei M, Malek-Khosravi S, Khazaie H (2011) The frequency of factor V Leiden mutation, ACE gene polymorphism, serum ACE activity and response to ACE inhibitor and angiotensin II receptor antagonist drugs in Iranians type II diabetic patients with microalbuminuria. Mol Biol Rep (in press)Google Scholar